Norgine

Norgine is a specialty pharmaceutical and consumer healthcare company generating over €500 million in annual revenue and serving more than 25 million patients across Western Europe, Australia, and New Zealand. With a 120‑year legacy, it focuses on hepatology, oncology, women's health, gastroenterology, and related supportive care, delivering high‑impact treatments through in‑licensing, out‑licensing, and strategic partnerships. The company’s integrated model—combining deep medical and regulatory expertise, robust in‑house manufacturing, and efficient supply networks—ensures rapid, high‑quality access to transformative medicines. Norgine’s culture of operational excellence, agility, and innovation sets it apart as a nimble, high‑performing player in the specialty pharma landscape.